The type III secretion system facilitates systemic infections of Pseudomonas aeruginosa in the clinic
IMPORTANCE: The identification of decisive virulence-associated genes in highly pathogenic P. aeruginosa isolates in the clinic is essential for diagnosis and the start of appropriate treatment. Over the past decades, P. aeruginosa ST463 has spread rapidly in East China and is highly resistant to β-lactams. Given the poor clinical outcome caused by this phenotype, detailed information regarding its decisive virulence genes and factors affecting virulence expression needs to be deciphered. Here, we demonstrate that the T3SS effector ExoU has toxic effects on mammalian cells and is required for virulence in the murine bloodstream infection model. Moreover, a functional downstream SpcU is required for ExoU secretion and cytotoxicity. This work highlights the potential role of ExoU in the pathogenesis of disease and provides a new perspective for further research on the development of new antimicrobials with antivirulence ability.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Microbiology spectrum - 12(2024), 1 vom: 11. Jan., Seite e0222423 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wu, Tiantian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 15.01.2024 Date Revised 15.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1128/spectrum.02224-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365792705 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365792705 | ||
003 | DE-627 | ||
005 | 20240115231948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/spectrum.02224-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1260.xml |
035 | |a (DE-627)NLM365792705 | ||
035 | |a (NLM)38088541 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wu, Tiantian |e verfasserin |4 aut | |
245 | 1 | 4 | |a The type III secretion system facilitates systemic infections of Pseudomonas aeruginosa in the clinic |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.01.2024 | ||
500 | |a Date Revised 15.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a IMPORTANCE: The identification of decisive virulence-associated genes in highly pathogenic P. aeruginosa isolates in the clinic is essential for diagnosis and the start of appropriate treatment. Over the past decades, P. aeruginosa ST463 has spread rapidly in East China and is highly resistant to β-lactams. Given the poor clinical outcome caused by this phenotype, detailed information regarding its decisive virulence genes and factors affecting virulence expression needs to be deciphered. Here, we demonstrate that the T3SS effector ExoU has toxic effects on mammalian cells and is required for virulence in the murine bloodstream infection model. Moreover, a functional downstream SpcU is required for ExoU secretion and cytotoxicity. This work highlights the potential role of ExoU in the pathogenesis of disease and provides a new perspective for further research on the development of new antimicrobials with antivirulence ability | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Pseudomonas aeruginosa | |
650 | 4 | |a ST463/O4 | |
650 | 4 | |a T3SS | |
650 | 4 | |a exoU | |
650 | 4 | |a high-risk clone | |
650 | 4 | |a virulence | |
650 | 7 | |a Type III Secretion Systems |2 NLM | |
650 | 7 | |a Virulence Factors |2 NLM | |
650 | 7 | |a Bacterial Proteins |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Zhang, Zhenchuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Tong |e verfasserin |4 aut | |
700 | 1 | |a Dong, Xu |e verfasserin |4 aut | |
700 | 1 | |a Wu, Dan |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Lixia |e verfasserin |4 aut | |
700 | 1 | |a Xu, Kaijin |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Ying |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Microbiology spectrum |d 2013 |g 12(2024), 1 vom: 11. Jan., Seite e0222423 |w (DE-627)NLM241847044 |x 2165-0497 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2024 |g number:1 |g day:11 |g month:01 |g pages:e0222423 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/spectrum.02224-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2024 |e 1 |b 11 |c 01 |h e0222423 |